Life sciences
Biotechnology: Industry position survey 2012
Grant Thornton and AusBiotech are committed to working with participants in the biotechnology industry to address issues of importance to them. We are proud to present the findings of our 2012 CEO Industry Position Survey which provides a comprehensive view of issues affecting the industry.
The life sciences industry is a lively sector, characterised by dynamic change, vitality and long-term growth. Our globalising economy and the rapidly evolving needs of its diverse markets present virtually limitless opportunities for businesses in the life sciences sector.
But successfully navigating life sciences’ choppy business waters is a continuous challenge, and your enterprise can be all too easily steered off course by issues as disparate and unpredictable as:
- threats to your business and product
- lengthy, high-cost product development cycles
- demanding change management
Whether your life sciences company concentrates on pharmaceuticals, medical-device manufacturing, bio-engineering or other science-based technology-driven business pursuits, Grant Thornton life sciences practice can help.
Years of successfully working with life sciences leaders and the ability to draw on a dedicated team of skilled, knowledgeable professionals enable us to provide a comprehensive range of audit, tax and advisory services to support your business and financial strategies. We help your life sciences company achieve real competitive advantage, now and into the future.
For more information on Grant Thornton's focus on the biotechnology industry, contact your usual Grant Thornton advisor, or:
Michael Cunningham
Industry Leader - Life Sciences
T +61 3 8663 6007
M +61 402 394 608
E michael.cunningham@au.gt.com
Further reading from Grant Thornton Australia
Services to the life sciences sector
Further reading from Grant Thornton International
*New* Strategies for success in today's competitive life sciences market (from Grant Thornton US)
Insights for life sciences businesses: Funding strategies (from Grant Thornton US)
Funding options for Drug Discovery Companies: A report on national and international models (from Grant Thornton India)
Biotech under the Public Private Partnership (PPP) model: A report on opportunities and challenges (from Grant Thornton India)
Contact us
To find out more information about Grant Thornton or provide feedback to us, click here to contact us